English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Kapsera raises €4.2M to accelerate industrialization for sustainable agriculture and healthier foodqrcode

Dec. 11, 2024

Favorites Print
Forward
Dec. 11, 2024

Kapsera SAS
France  France
Follow

Kapsera, a pioneer in sustainable microencapsulation for agriculture and food sectors, has announced a €4.2 million funding round to advance its industrialization and commercialization phase. This significant step is made possible through the entry of two new investors: Banque des Territoires, committed to financing and supporting projects of public interest developed by regional actors, and The Yield Lab Europe, an investment fund specialized in ecological transition and sustainable innovation. Kapsera also benefits from renewed support from its longstanding shareholders, including Demeter Investment Managers via its Agrinnovation fund, which has supported Kapsera since 2019.


This funding will enable Kapsera to establish its first industrial units at its Bordeaux site in the Nouvelle-Aquitaine region, which also supports the company through its VitiREV program, a France 2030 – Territories of Innovation winner. The company aims to achieve an annual production capacity exceeding 200 tons by 2027 and plans to create 20 jobs in the next two years. The first unit is expected to be operational by the second quarter of 2025.


Alongside industrialization, Kapsera will intensify its R&D efforts to expand its range of natural microcapsules. These innovations address the growing demand for biosolutions in agriculture and human or animal nutrition. The company will also continue optimizing its proprietary process to maintain its technological edge and provide increasingly efficient and sustainable solutions to its clients.


广告1.gif


Kapsera reaffirms its ambition to become a global leader in natural microencapsulation solutions for life sciences, positioned at the intersection of technological innovation and sustainability.


"This funding marks a pivotal step in Kapsera's development. It allows us to initiate our industrialization phase to support our clients in their commercial ambitions and their desire to offer high-performance, sustainable, and healthy solutions in their markets" said Antoine Drevelle, CEO and co-founder of Kapsera.


He added: "We are delighted to welcome two visionary investors who share our ambition to accelerate the transition toward sustainable agriculture and healthy food. They join our historical shareholders, the Nouvelle-Aquitaine Region, and Bpifrance. Together, we will tackle major challenges related to the food systems of tomorrow."


François Wohrer, Head of Investment at Banque des Territoires, commented: "We are pleased to invest in Kapsera. This investment, made through the France 2030 Territoires d'Innovation program managed by Banque des Territoires, will facilitate the construction of the first factory and help address the challenge of developing sustainable agriculture that is less reliant on chemical inputs while remaining productive."


Cyrille Cabaret, Partner at Demeter Investment Managers, remarked: "Since our initial investment in 2019, we have been proud to support Kapsera’s R&D milestones, which have led to the development of a unique encapsulation technology. With this new funding round, we reaffirm our support for the industrialization phase, enabling the company to serve high-growth markets such as agriculture, human nutrition, and animal nutrition."


Gentiane Gorlier, General Partner at The Yield Lab Europe, added: "We are always on the lookout for innovative technologies that address real-world challenges. We were immediately impressed by the Kapsera team and their natural microencapsulation technology, which solves multiple bottlenecks in feed, food, and applications like biopesticides, biostimulants, and pheromones. We are proud to support Kapsera in this new phase of commercial and industrial development."


Source: Kapsera

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe BioEx Biweekly to send news related to your mailbox